Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ

Genes and Development

Volumn 13, Issue 12, 1999, Pages 1561-1574

  Lim, Hyunjung ^a   Gupta, Rajnish A ^b   Ma, Wen Ge ^a   Paria, Bibhash C ^a   Moller, David E ^c   Morrow, Jason D ^b   DuBois, Raymond N ^b   Trzaskos, James M ^d   Dey, Sudhansu K ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d DUPONT COMPANY   (United States)

Author keywords

COX2; Implantation; Mouse; PPAR ; Prostaglandins

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLOOXYGENASE 2; HORMONE RECEPTOR; PROSTACYCLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLASTOCYST; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DECIDUALIZATION; ENZYME MECHANISM; FEMALE; MOUSE; NIDATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STROMA CELL; TRANSCRIPTION REGULATION;

ANIMALIA; MAMMALIA;

EID: 0033564698     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.12.1561     Document Type: Article

References (74)

1. Altiok, S., M. Xu, and B.M. Spiegelman. 1997. PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes & Dev. 11: 1987-1998.
2. Berger, J., M.D. Leibowitz, T.W. Doebber, A. Elbrecht, B. Zhang, G. Zhou, C. Biswas, C.A. Cullinan, N.S. Hayes, Y. Li, M. Tanen, J. Ventre, M.S. Wu, G.D. Berger, R. Mosley, R. Marquis, C. Santini, S.P. Sahoo, R.L. Tolman, R.G. Smith, and D.E. Moller. 1999. Novel PPAR-γ and PPARδ ligands produce distinct biological effects. J. Biol. Chem. 274: 6718-6725.
3. Bilinski, P., D. Roopentian, and A. Gossler. 1998. Maternal IL-11Rα function is required for normal decidua and fetoplacental development in mice. Genes & Dev. 12: 2234-2243.
4. Braissant, O. and W. Wahli. 1998. Differential expression of peroxisome proliferator-activated receptors-α, -β, and -γ during rat embryonic development. Endocrinology 139: 2748-2754.
5. Braissant, O., F. Foufelle, C. Scotto, M. Dauca, and W. Wahli. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137: 354-366.
6. Chakraborty, I., S.K. Das, and S.K. Dey. 1995. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation. J. Endocrinol. 147: 339-352.
7. Chakraborty, I., S.K. Das, J. Wang, and S.K. Dey. 1996. Developmental expression of the cyclo-oxygenase-1 and cyclooxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J. Mol. Endocrinol. 16: 107-122.
8. Charpigny, G., P. Reinaud, J.P. Tamby, C. Creminon, and M. Guillomot. 1997. Cyclooxygenase-2 unlike cyclooxygenase-1 is highly expressed in ovine embryos during the implantation period. Biol. Reprod. 57: 1032-1040.
9. Cheskis, B. and L.P. Freedman. 1997. Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoic X receptor heterodimers. Mol. Cell. Biol. 14: 3329-3338.
10. Das, S.K., X.-N. Wang, B.C. Paria, D. Damm, J.A. Abraham, M. Klagsbrun, G.K. Andrews, and S.K. Dey. 1994. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: A possible ligand for interaction with blastocyst EGF-receptor in implantation. Development 120: 1071-1083.
11. Das, S.K., J. Wang, S.K. Dey, and R.A. Mead. 1999. Spatiotemporal expression of cyclooxygenase-1 and cyclooxygenase-2 during delayed implantation and periimplantation period in the western spotted skunk. Biol. Reprod. 60: 893-899.
12. Dawe, C.J., W.G. Banfield, W.D. Morgan, M.S. Slatick, and H.O. Curth. 1964. Growth in continuous culture, and in Hamsters, of cells from a neoplasm associated with Acanthosis Nigricans. J. Nat. Cancer Inst. 33: 441-456.
13. 4 pathway to inflammation control. Nature 384: 39-43.
14. Dey, S.K. 1996. Implantation. In Reproductive endocrinology, surgery, and technology (ed. E.Y. Adashi, J.A. Rock, and Z. Rosenwaks), pp. 421-434. Lippincott-Raven, Philadelphia, PA.
15. Dinchuk, J.E., B.D. Car, R.J. Focht, J.J. Johnston, B.D. Jaffee, M.B. Covington, N.R. Contel, V.M. Eng, R.J. Collins, P.M. Czerniak, S.A. Gorry, and J.M. Trzaskos. 1995. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406-409.
16. Direnzo, J., M. Soderstrom, R. Kurokawa, M. Ogliastro, M. Ricote, S. Ingrey, A. Horlein, M.G. Rosenfeld, and C.K. Glass. 1997. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol. Cell. Biol. 17: 2166-2176.
17. DuBois, R.N., J. Awad, J. Morrow, L.J. Roberts, and P.R. Bishop. 1994. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest. 93: 493-498.
18. Dubois, R.N., S.B. Abramson, L. Crofford, R.A. Gupta, L.S. Simon, L.B. Van De Putte, and P.E. Lipsky. 1998. Cyclooxygenase in biology and disease. FASEB J. 12: 1063-1073.
19. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83: 803-812.
20. Forman, B.M., J. Chen, and R.M. Evans. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl. Acad. Sci. 94: 4312-4317.
21. Geraci, M., D. Shepherd, M. Moore, J. Vernon, J. Allard, J. Shannon, and N.F. Voelkel. 1997. Cloning and regulation of gene expression in the lung. Chest 111: 129S.
22. Huet-Hudson, Y.M., G.K. Andrews, and S.K. Dey. 1989. Cell type-specific localization of c-Myc protein in the mouse uterus: Modulation by steroid hormones and analysis of the periimplantation period. Endocrinology 125: 1638-1690.
23. Isseman, I. and S. Green. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-650.
24. Jiang, C., A.T. Ting, and B. Seed. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86.
25. Jones, D.A., D.P. Carlton, T.M. McIntyre, G.A. Zimmerman, and S.M. Prescott. 1993. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 268: 9049-9054.
26. Kastner, P., J.M. Grondona, M. Mark, A. Gansmuller, M. LeMeur, D. Decimo, J.L. Vonesch, P. Dolle, and P. Chambon. 1994. Genetic analysis of RXR alpha developmental function: Convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 78: 987-1003.
27. 2 receptor. Nat. Med. 5: 217-220.
28. Kim, J.J., J. Wang, C. Bambra, S.K. Das, S.K. Dey, and A.T. Fazleabas. 1999. Expression of cyclooxygenase-1 and -2 in the baboon endometrium during the menstrual cycle and pregnancy. Endocrinology 140: 2672-2678.
29. Kliewer, S.A., K. Umenoso, D.J. Noonan, R.A. Heyman, and R.M. Evans. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774.
30. Kliewer, S.A., B.M. Forman, B. Blumberg, E.S. Ong, U. Borgmeyer, D.J. Mangelsdorf, K. Umenoso, and R.M. Evans. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. 91: 7355-7359.
31. 2 metabolite binds peroxisome proliferator activated receptor-γ and promotes adipocyte differentiation. Cell 83: 813-819.
32. Kliewer, S.A., S.S. Sundseth, S.A. Jones, P.J. Brown, G.B. Wisley, C.S. Koble, P. Devchand, W. Wahli, T.M. Willson, J.M. Lenhard, and J.M. Lehmann. 1997. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors a and γ. Proc. Natl. Acad. Sci. 94: 4318-4323.
33. Krezel, W., V. Dupe, M. Mark, A. Dierich, P. Kastner, and P. Chambon. 1996. RXRγ null mice are apparently normal and compound RXRα+/-/RXRβ-/-/RXRγ-/-mutant mice are viable. Proc. Natl. Acad. Sci. 93: 9010-9014.
34. Langenbach, R., S.G. Morham, H.F. Tiano, C.D. Loftin, B.I. Ghanayem, P.C. Chulada, J.F. Mahler, C.A. Lee, E.H. Goulding, K.D. Kluckman, H.S. Kim, and O. Smithies. 1995. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83: 438-492.
35. Lee, S.S., T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez-Salguero, H. Westphal, and F.J. Gonzalez. 1995. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15: 3012-3022.
36. 2 gene expression in the mouse uterus coincides with differentiation of the luminal epithelium for implantation. Endocrinology 138: 4599-4606.
37. Lim, H., B.C. Paria, S.K. Das, J.E. Dinchuk, R. Langenbach, J.M. Trzaskos, and S.K. Dey. 1997. Multiple female reproductive failures in cyclooxygenase-2 deficient mice. Cell 91: 197-208.
38. Mangelsdorf, D.J. and R.M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83: 841-850.
39. Mangelsdorf, D.J., U. Borgmeyer, R.A. Heyman, J.Y. Zhou, E.S. Ong, A. Kakizuka, and R.M. Evans. 1992. Characterization of three RXR genes that mediate the action of 9-tis-retinoic acid. Genes & Dev. 6: 329-344.
40. Moncada, S. 1983. Biology and therapeutic potential of prostacyclin. Stroke 14: 157-168.
41. Motojima, K., P. Passilly, J.M. Peters, F.J. Gonzalez, and N. Latruffe. 1998. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue-and inducer-specific manner. J. Biol. Chem. 273: 16710-16714.
42. Mueller, E., P. Sarraf, P. Tontonoz, R.M. Evans, K.J. Martin, M. Zhang, C. Fletcher, S. Singer, and B.M. Spiegelman. 1998. Terminal differentiation of human breast cancer through PPARγ. Mol. Cell 1: 465-470.
43. Muerhoff, A.S., K.J. Griffin, and E.F. Johnson. 1992. The peroxisomal proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid ω-hydroxylase, by clofibric acid. J. Biol. Chem. 267: 19051-19053.
44. Mukherjee, R., P.J. Davies, D.L. Crombie, E.D. Bischoff, R.M. Cesario, L. Jow, L.G. Hamann, M.F. Boehm, C.E. Mondon, A.M. Nadzan, J.R. Paterniti, and R.A. Heyman. 1997. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386: 407-410.
45. Murata, T., F. Ushikubi, T. Matsuoka, M. Hirata, A. Yamasaki, Y. Sugimoto, A. Ichikawa, Y. Aze, T. Tanaka, N. Yoshida, A. Ueno, S. Oh-ishi, and S. Narumiya. 1997. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388: 678-682.
46. Murohara, T., J. Horowitz, M. Silver, Y. Tsurumi, D. Chen, A. Sullivan, and J. Isner. 1998. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97: 99-107.
47. Namba, T., H. Oida, Y. Sugimoto, A. Kakizuka, M. Negishi, A. Ichikawa, and S. Narumiya. 1994. cDNA cloning of a mouse prostacyclin receptor. J. Biol. Chem. 269: 9986-9992.
48. Negishi, M., Y. Sugimoto, and A. Ichikawa. 1995. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta 1259: 109-120.
49. 4 triggers remodelling of the cardiovascular system at birth. Nature 390: 78-81.
50. Paria, B.C., Y.M. Huet-Hudson, and S.K. Dey. 1993 Blastocyst's state of activity determines the 'window' of implantation in the mouse receptive uterus. Proc. Natl. Acad. Sci. 90: 10159-10162.
51. Reddy, J.K. and T.P. Krishnakantha. 1975. Hepatic perxisome proliferation: Induction by two novel compounds structurally unrelated to clofibrate. Science 200: 787-789.
52. Ricote, M., A.C. Li, T.M. Wilson, C.J. Kelly, and C.K. Glass. 1998. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391: 79-81.
53. Schoonjans, K., B. Staels, and J. Auwerx. 1996a. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1302: 93-109.
54. Schoonjans, K., J. Peinado-Onsurbe, A. Lefebvre, R.A. Heyman, M. Briggs, S. Deeb, B. Staels, and J. Auwerx. 1996b. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15: 5336-5348.
55. Schulman, I.G., G. Shao, and R.A. Heyman. 1998. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor γ (PPARγ) heterodimers: Intermolecular synergy requires only the PPARγ hormone-dependent activation function. Mol. Cell. Biol. 18: 3483-3494.
56. Smith, W.L. and D.L. DeWitt. 1996. Prostaglandin endoperoxide H synthase-1 and -2. Adv. Immunol. 62: 167-215.
57. 2 synthase antigen in smooth muscle cells. J. Biol. Chem. 258: 5922-5926.
58. Song, J.H., J. Sirois, A. Houde, and B.D. Murphy. 1998. Cloning, developmental expression and immunohistochemistry of cyclooxygenase 2 (COX2) in the endometrium during embryo implantation and gestation in the mink. Endocrinology 139: 3629-3636.
59. Spencer, A.G., J.W. Woods, T. Arakawa, I.I. Singer, and W.L. Smith. 1998. Subcellular localization of prostaglandin endoperoxide synthase-1 and -2 by immunoelectron microscopy. J. Biol. Chem. 273: 9886-9893.
60. Staels, B., W. Koenig, A. Habib, R. Merval, M. Lebret, I.P. Torra, P. Delerive, A. Fadel, G. Chinetti, J.C. Fruchart, J. Najib, J. Maclouf, and A. Tedgui. 1998. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 393: 790-793.
61. Tone, Y., H. Inoue, S. Hara, C. Yokoyma, T. Hatae, H. Oida, S. Narumiya, R. Shigemoto, S. Yukawa, and T. Tanabe. 1997. The regional distribution and cellular localization of mRNA encoding rat prostacyclin synthase. Eur. J. Cell Biol. 72: 268-277.
62. Tontonoz, P., E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman. 1994. mPPARγ2: Tissue-specific regulator of an adipocyte enhancer. Genes & Dev. 8: 1224-1234.
63. Tontonoz, P., S. Singer, B.M. Forman, P. Sarraf, J.A. Fletcher, C.D.M. Fletcher, R.P. Brun, E. Mueller, S. Altiok, H. Oppenheim, R.M. Evans, and B.M. Spiegelman. 1997. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl. Acad. Sci. 94: 237-241.
64. Tontonoz, P., L. Nagy, J.G. Alvarez, V.A. Thomazy, and R.M. Evans. 1998. PPARγ promotes monocyte-macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252.
65. Tsujii, M., S. Kawano, S. Tsuji, H. Sawaoka, M. Hori, and R.N. DuBois. 1998. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716.
66. Tugwood, J.D., I. Isseman, R.G. Anderson, K. Bundell, W. McPheat, and S. Green. 1992. The mouse peroxisome proliferator activated receptors recognizes a response element in the 5′-flanking sequence of rat acyl CoA oxidase gene. EMBO J. 11: 433-439.
67. 3. Nature 395: 281-284.
68. Wang, Z.M., S.K. Das, J. Wang, Y. Sugimoto, A. Ichikawa, and S.K. Dey. 1997. Potential sites of prostaglandin actions in the periimplantation mouse uterus: Differential expression and regulation of prostaglandin receptor genes. Biol. Reprod. 56: 368-379.
69. Wheeler-Jones, C., R. Abu-Ghazaleh, R. Cospedal, R.A. Houliston, J. Martin, and I. Zachary. 1997. Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Letts. 420: 28-32.
70. Xu, J., Y. Qiu, F.J. DeMayo, S.Y. Tsai, M.-J. Tsai, and B.W. O'Malley. 1998. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279: 1922-1925.
71. Yang, Z.M., S.K. Das, J. Wang, Y. Sugimoto, A. Ichikawa, and S.K. Dey. 1997. Potential sites of prostaglandin actions in the periimplantation mouse uterus: Differential expression and regulation of prostaglandin receptor genes. Biol. Reprod. 56: 368-379.
72. Yao, T.P., B.M. Forman, Z. Jiang, L. Cherbas, F.O. Chen, M. McKeown, P. Cherbas, and R.M. Evans. 1993. Functional ecdysone receptor is the product of EcR and Ultraspiracle genes. Nature 366: 476-479.
73. Zhang, X.K., J. Lehmann, B. Hoffmann, M.I. Dawson, J. Cameron, G. Graupner, P. Tran, and M.M. Pfahl. 1992. Homodimer formation of retinoid X receptor induced by 9-cis-retinoic acid. Nature 358: 587-591.
74. Zhou, G., R. Cummings, Y. Li, S. Mitra, H.A. Wilkinson, A. Elbrecht, J.D. Hermes, J.M. Schaeffer, R.G. Smith, and D.E. Moller. 1998. Nuclear receptors have distinct affinities for coactivators: Characterization by fluorescence resonance energy transfer. Mol. Endocrinol. 12: 1594-1604.